JP2013515079A5 - - Google Patents

Download PDF

Info

Publication number
JP2013515079A5
JP2013515079A5 JP2012546164A JP2012546164A JP2013515079A5 JP 2013515079 A5 JP2013515079 A5 JP 2013515079A5 JP 2012546164 A JP2012546164 A JP 2012546164A JP 2012546164 A JP2012546164 A JP 2012546164A JP 2013515079 A5 JP2013515079 A5 JP 2013515079A5
Authority
JP
Japan
Prior art keywords
therapeutic agent
agent according
seq
antibody
pseudomonas aeruginosa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012546164A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013515079A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/061636 external-priority patent/WO2011087799A1/en
Publication of JP2013515079A publication Critical patent/JP2013515079A/ja
Publication of JP2013515079A5 publication Critical patent/JP2013515079A5/ja
Pending legal-status Critical Current

Links

JP2012546164A 2009-12-22 2010-12-21 低レベルの病原性シュードモナス・エルギノーサ（Ｐｓｅｕｄｏｍｏｎａｓａｅｒｕｇｉｎｏｓａ）感染症を有する患者のスタフィロコッカス（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ）感染症を治療する方法 Pending JP2013515079A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28897709P 2009-12-22 2009-12-22
US61/288,977 2009-12-22
PCT/US2010/061636 WO2011087799A1 (en) 2009-12-22 2010-12-21 A method of treating a staphylococcus infection in a patient having a low-level pathogenic pseudomonas aeruginosa infection

Publications (2)

Publication Number Publication Date
JP2013515079A JP2013515079A (ja) 2013-05-02
JP2013515079A5 true JP2013515079A5 (https=) 2014-05-29

Family

ID=44224810

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012546164A Pending JP2013515079A (ja) 2009-12-22 2010-12-21 低レベルの病原性シュードモナス・エルギノーサ（Ｐｓｅｕｄｏｍｏｎａｓａｅｒｕｇｉｎｏｓａ）感染症を有する患者のスタフィロコッカス（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ）感染症を治療する方法

Country Status (5)

Country Link
US (1) US8642039B2 (https=)
EP (1) EP2515935A4 (https=)
JP (1) JP2013515079A (https=)
CA (1) CA2784033A1 (https=)
WO (1) WO2011087799A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8597689B2 (en) * 2006-10-25 2013-12-03 Revalesio Corporation Methods of wound care and treatment
US10125359B2 (en) 2007-10-25 2018-11-13 Revalesio Corporation Compositions and methods for treating inflammation
US20090263495A1 (en) * 2007-10-25 2009-10-22 Revalesio Corporation Bacteriostatic or bacteriocidal compositions and methods
US9745567B2 (en) 2008-04-28 2017-08-29 Revalesio Corporation Compositions and methods for treating multiple sclerosis
US9523090B2 (en) 2007-10-25 2016-12-20 Revalesio Corporation Compositions and methods for treating inflammation
US20100310665A1 (en) * 2007-10-25 2010-12-09 Revalesio Corporation Bacteriostatic or bacteriocidal compositions and methods
US8815292B2 (en) 2009-04-27 2014-08-26 Revalesio Corporation Compositions and methods for treating insulin resistance and diabetes mellitus
BR112012028540A2 (pt) 2010-05-07 2016-07-26 Revalesio Corp composições e métodos para melhorar desempenho fisiológico e tempo de recuperação
JP2013533320A (ja) 2010-08-12 2013-08-22 レバレジオ コーポレイション タウオパチーを治療するための組成物および方法
BR112013031485B1 (pt) 2011-06-10 2022-06-14 Medimmune, Llc Anticorpo monoclonal isolado ou fragmento de ligação a antígeno do mesmo, composição farmacêutica, usos e método in vitro para bloqueio ou prevenção da ligação de p. aeruginosa a células epiteliais
BR112014011028B1 (pt) 2011-11-07 2021-03-02 Medimmune, Llc anticorpo biespecífico, composição, e, uso da composição
TWI719938B (zh) * 2014-06-19 2021-03-01 美商麥迪紐有限責任公司 多重細菌感染之治療
EP3288974B1 (en) 2015-05-01 2020-11-04 Inhibrx, Inc. Type iii secretion system targeting molecules
CN113811544A (zh) 2019-03-13 2021-12-17 免疫医疗有限责任公司 减少定殖患者中的金黄色葡萄球菌感染
CN118620074A (zh) * 2020-06-01 2024-09-10 北京三诺佳邑生物技术有限责任公司 特异性识别假单胞菌pcrv的抗体及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69930166T2 (de) * 1998-11-25 2006-12-14 MCW Research Foundation, Inc., Milwaukee Verfahren und zusammensetzungen für impfung mit dem pseudomonas aeruginosa v-antigen
EP2316419B1 (en) * 2004-05-17 2012-07-11 Gilead Sciences, Inc. Aerosolized fosfomycin/tobramycin combination for the treatment of bacterial respiratory infections
US20060228384A1 (en) * 2005-04-06 2006-10-12 Sequoia Sciences, Inc. Control of biofilm with a biofilm inhibitor
US8268347B1 (en) * 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
BRPI0817311A2 (pt) * 2007-09-25 2015-03-17 Novartis Ag Tratamento de doenças pulmonares com medicamentos em aerossol tais como a vancomicina
EP2220117A2 (en) * 2007-11-30 2010-08-25 Kalobios Pharmaceuticals, Inc. Antibodies to the pcrv antigen of pseudomonas aeruginosa
WO2010091189A1 (en) 2009-02-04 2010-08-12 Kalobios Pharmaceuticals, Inc. Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection

Similar Documents

Publication Publication Date Title
JP2013515079A5 (https=)
JP2021063090A5 (https=)
JP2017519768A5 (https=)
JP6845016B2 (ja) 多細菌性感染の治療
US20240350634A1 (en) Monoclonal antibody and vaccine targeting filamentous bacteriophage
US8653242B2 (en) Therapeutic antibodies against flagellated Pseudomonas aeruginosa
ES2529175T3 (es) Anticuerpo monoclonal humano contra la toxina alfa derivada de S. aureus y su uso en el tratamiento o la prevención de la formación de abscesos
JP2019031567A5 (https=)
SI3064511T1 (en) THE MEDICINE USE OF HUMAN HIGHLIGHTS FOR HUMAN RECEPTOR IL-4
JP2009511480A5 (https=)
JP2016507470A5 (https=)
JP2011506483A5 (https=)
JP2005516044A (ja) モノクローナル抗体の鼻内投与によるブドウ球菌の鼻コロニー形成を阻止又は緩和する方法
JP2006511516A5 (https=)
JP2006522830A5 (https=)
CA2687681A1 (en) Antigen-binding proteins targeting s. aureus orf0657n
JP2022163050A (ja) 院内肺炎を予防または治療する方法
JP2017515473A5 (https=)
WO2021052461A1 (zh) 抗α-溶血素的抗体及其应用
JP2006514636A5 (https=)
CN104870472A (zh) 抗空肠弯曲杆菌抗体及其用途
JP2019521156A5 (https=)
JP2018529661A5 (https=)
JP2012516897A5 (https=)
JP2002501487A (ja) トリの抗体の使用法